Article
No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression.
Neuropsychobiology - 1 Jan 2007
Kato Masaki, Wakeno Masataka, Okugawa Gaku, Fukuda Tsuyoshi, Azuma Junichi, Kinoshita Toshihiko, Serretti Alessandro
Abstract excerpt
BACKGROUND: Variability in antidepressant response is due to genetic and environmental factors. Since SSRIs exert their activity enhancing the serotonin turnover, genes coding for proteins of the serotonin system are key candidates for a possible genetic influence with response to SSRIs. Therefore tryptophan hydroxylase (TPH), the rate-limiting enzyme in the biosynthesis of serotonin in the raphe nuclei could be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
